Divi's Laboratories per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹110.21₹96.75₹82.53₹60.27₹68.69
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹110.21₹96.75₹82.53₹60.27₹68.69
₹632.49₹632.49₹564.87₹512.11₹480.96
₹423.77₹398.49₹353.21₹296.04₹292.62
—₹103.32₹62.38₹47.58₹92.66
₹8.23₹8.23₹8.11₹9.74₹74.84
—₹30.08₹30.04₹30.04₹30.00
26.526.526.526.526.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

DIVISLAB₹9,558.50

Divi's Laboratories Ltd.

· Pharma & Health
₹ CrorePeersLAURUSLABSCOHANCEGLANDTORNTPHARMZYDUSLIFEMAXHEALTHDRREDDYCIPLAMcap ₹2.53L Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS68.6960.2782.5396.75110.21
Diluted EPS68.6960.2782.5396.75110.21
Book Value per Share480.96512.11564.87632.49632.49
Revenue per Share292.62296.04353.21398.49423.77
Cash Flow per Share92.6647.5862.38103.32—
Free Cash Flow per Share74.849.748.118.238.23
Dividends per Share30.0030.0430.0430.08—
Shares Outstanding (cr)26.526.526.526.526.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.